Ion Exchange India Ltd-$ — earnings calls

Ion Exchange reported consolidated Q1 FY27 operating income of INR 701 crores, up 20% year-on-year, while EBITDA declined 49% to INR 32 crores and net profit was INR 3 crores. Management introduced a reclassification of reporting segments, splitting the former engineering segment into Treatment Solutions, Industrial Products and Lifecycle Services, alongside existing Specialty Chemicals and Consumer Products segments. Management attributed the profitability decline to legacy project losses in Treatment Solutions, higher input and Roha-related costs in Specialty Chemicals, and geopolitical factors affecting invoicing and raw material costs.

Ion Exchange reported Q4 FY26 consolidated operating income of INR 8,633 million, up around 3% year-on-year, with EBITDA of INR 199 million and net profit of INR 243 million. For full-year FY26, operating income rose about 7% to INR 29,148 million while EBITDA fell 29% year-on-year to INR 2,102 million. Management attributed margin pressure in the engineering and chemicals segments to disruptions from the West Asia crisis, higher input costs, and Roha facility depreciation and interest charges, while highlighting commissioning of the Roha plant, a technology partnership with MANN+HUMMEL, and progress on the Oman DBOOT project.